QTc prolongation and diabetes therapies

Diabet Med. 2012 Mar;29(3):290-2. doi: 10.1111/j.1464-5491.2011.03520.x.

Authors

K Watters¹, N Munro, M Feher

Affiliation

¹ Diabetes Therapies Evaluation Net Network (DTENet), London, UK.

PMID: 22060961
DOI: 10.1111/j.1464-5491.2011.03520.x

No abstract available

MeSH terms

Anti-Arrhythmia Agents / adverse effects*
Diabetes Mellitus, Type 1 / complications*
Diabetes Mellitus, Type 1 / drug therapy
Diabetes Mellitus, Type 2 / complications*
Diabetes Mellitus, Type 2 / drug therapy
Diabetic Angiopathies / chemically induced
Diabetic Angiopathies / etiology*
Electrocardiography
Humans
Long QT Syndrome / chemically induced
Long QT Syndrome / etiology*
Risk Factors
Vasodilator Agents / adverse effects*

Substances

Anti-Arrhythmia Agents
Vasodilator Agents